Daito Pharmaceutical Co., Ltd.

FDA inspection history in Toyama-City, Japan, 2017 to 2023

4
Form 483s

Every document, by year

  • Form 483

2017: one Form 483; 2020: one Form 483; 2022: one Form 483; 2023: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2017One Form 483, at Toyama-City, Japan.
  2. 2020–23Three Form 483s, at Toyama-City, Japan.
  3. 2020The longest 483 on file: 10 observations over 3 pages at Toyama-City, Japan.

Cited most

Across all Daito Pharmaceutical Co. observations on file

The complete Daito Pharmaceutical Co. file.

All 4 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$396

The price of the documents, added to your cart together

Sites

Documents

4 on file, newest first
DateDocumentPrice
2023-12-19483 Form 483$99
2022-09-16483 Form 483$99
2020-01-31483 Form 483$99
2017-11-10483 Form 483$99

FEI number 3002806779 · most recent document Dec 19, 2023

About Daito Pharmaceutical Co., Ltd.

How many FDA Form 483s has Daito Pharmaceutical Co., Ltd. received?

FDA Intel has 4 Form 483s on file for Daito Pharmaceutical Co., Ltd.; the most recent is dated Dec 19, 2023.

When was Daito Pharmaceutical Co., Ltd. last inspected by FDA?

The most recent FDA inspection document on file for Daito Pharmaceutical Co., Ltd. is a Form 483 dated Dec 19, 2023, for the site in Toyama-City, Japan.

What did FDA cite at Daito Pharmaceutical Co., Ltd.?

The regulations cited most in the observations on file for Daito Pharmaceutical Co., Ltd. are 21 CFR 211.22 (Responsibilities of quality control unit), 6 times; 21 CFR 211.68 (Automatic, mechanical, and electronic equipment), 4 times; 21 CFR 211.192 (Production record review), 3 times.